Cargando…
Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
C. difficile infection (CDI) is rarely reported in cystic fibrosis (CF) patients despite frequent hospitalisations and antibiotic usage. Conversely, the prevalence of CDI in inflammatory bowel disease (IBD) has received increased attention. We investigated components of the IgG-specific humoral immu...
Autores principales: | Monaghan, Tanya M., Robins, Adrian, Knox, Alan, Sewell, Herbert F., Mahida, Yashwant R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769242/ https://www.ncbi.nlm.nih.gov/pubmed/24058568 http://dx.doi.org/10.1371/journal.pone.0074452 |
Ejemplares similares
-
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
por: Monaghan, Tanya M, et al.
Publicado: (2017) -
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infection (C. difficile-associated diarrhoea) in Ireland
por: van Engen, Anke, et al.
Publicado: (2015) -
Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection
por: Alonso, Carolyn D, et al.
Publicado: (2021) -
The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis
por: Bilverstone, Terry W., et al.
Publicado: (2020) -
C. difficile associated diarrhoea-don’t blame community or norovirus
por: Damani, N, et al.
Publicado: (2011)